3,156 followers
An open-label, prospective interventional study of the tolerability and efficacy of 0.4mg oral tamsulosin oral in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin h